Efficacy of the Percutaneus Endoscopic Gastrojejunostomy (PEG-J) tube decompression therapy for patients with chronic intestinal pseudo-obstruction (CIPO)

Efficacy of the Percutaneus Endoscopic Gastrojejunostomy (PEG-J) tube decompression therapy for patients with chronic intestinal pseudo-obstruction (CIPO) - Efficacy of the PEG-J tube decompression therapy for the CIPO patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017574

Enrollment

Registered

2015-06-01

Start date

2015-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic intestinal pseudo-obstruction(CIPO)

Interventions

Percutaneus endoscopic gastrojejunostomy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients who meet the diagnostic criteria for CIPO proposed by Ministry of Health, Labor, and Welfare. 2) Patients of whom written informed consent was obtained.

Exclusion criteria

Exclusion criteria: 1) Patients with organic digestive tract disease. 2) Patients with current or past history of malignant disease. 3) Patients with current other digestive diseases. 4) Patients with psychiatric disorders. 5) Patients judged inappropriate for the trial by investigators.

Design outcomes

Primary

Measure	Time frame
1) Diameter of the small intestine before and after PEG-J. 2) Frequency of abdominal pain, bloating, and nausea	—

Countries

Japan

Contacts

Public ContactHidenori Ohkubo

Yokohama City University School of Medicine Department of Gastroenterology and Hepatology

ohkuboh@yokohama-cu.ac.jp045-787-2640

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026